BayWa’s Creditors Hold the Key as a €2.7 Billion Gap and a Legal Onslaught Converge

BayWa's rescue plan unravels as US renewable subsidies vanish, leaving a €2.7B gap. Legal claims and a NZ asset sale offer little relief.

The restructuring of BayWa, the Munich-based agricultural and construction materials group, is entering a perilous phase. A dramatic shift in US energy policy has torpedoed the centerpiece of its rescue plan, while a mounting legal offensive from shareholders and regulators adds a new layer of uncertainty. The company’s survival now hinges on a single, critical vote from its core lenders.

The US Policy Shock That Broke the Plan

The cornerstone of BayWa’s recovery was the planned sale of a 51% stake in its renewable energy subsidiary, BayWa r.e., which was expected to fetch up to €1.7 billion. That deal has been effectively destroyed by the US “One Big Beautiful Bill Act,” which slashes subsidies for renewable energy. The damage is twofold: not only has the sale become unviable, but the unit’s own profit outlook has collapsed. BayWa now expects an EBITDA of just €150 million from the division in 2030, down sharply from a previous forecast of €230 million for 2028.

This leaves a yawning hole in the company’s overall restructuring target of €4 billion by 2028. So far, only about 33% of that goal—roughly €1.3 billion—has been secured. That leaves €2.7 billion still to be found, with the energy business alone having accounted for around €2 billion of the missing sum.

A Kiwi Unit as a Stopgap, Not a Solution

As a partial remedy, Goldman Sachs has been marketing BayWa’s 74% stake in New Zealand fruit trader T&G Global since March 2026. T&G, which owns popular apple brands like Envy and Jazz and sells to over 60 countries, posted revenue of $1.3 billion in 2024 and returned to profitability. The expected proceeds from the sale are around €300 million—a fraction of what is needed.

The process is far from smooth. Joy Wing Mau Group, a Hong Kong-based minority shareholder that holds nearly 20% of T&G, is reportedly complicating the sale. T&G itself has stressed that no decision has been made. Even if the deal closes, the sum will barely dent the financing gap.

Legal Storm Brews on Multiple Fronts

While the company scrambles to raise cash, it is also fending off a legal assault. The Tübingen-based law firm TILP is preparing mass damages claims on behalf of aggrieved shareholders. The basis is a formal reprimand from the German financial regulator BaFin, which found that BayWa omitted key details from its 2023 management report regarding a billion-euro loan and the risks tied to a €500 million bond. Anyone who bought shares between January 2022 and January 2026 is considered potentially eligible to join the claims.

Separately, the Munich public prosecutor’s office is investigating former CEOs Klaus Josef Lutz and Marcus Pöllinger on suspicion of breach of trust and misrepresentation in the 2023 annual accounts. Raids were carried out in January. All parties maintain the presumption of innocence.

The company’s auditor, PwC, is also under scrutiny. The German audit oversight body, Apas, has opened a professional conduct review after PwC issued an unqualified audit opinion for 2023 without flagging existential risks. BayWa is now tendering the audit mandate for 2026 and is exploring claims for damages against its former auditors.

Internal Controls Tighten as the Clock Ticks

Internally, the supervisory board is tightening its grip. The approval threshold for major transactions has been slashed from €200 million to €50 million. The management board has withdrawn its 2026 forecast and lowered the adjusted EBITDA target for 2027 to around €140 million. The long-term plan is to shrink the group from a €24 billion conglomerate to a focused agricultural and building materials business with roughly €10 billion in annual revenue, shedding about 1,300 jobs in the process.

The next concrete data point comes on May 6, when BayWa publishes its first-quarter 2026 report. That will be the first real test of whether cost-cutting measures are taking effect at the operational level.

The Real Decision Lies with the Banks

For all the drama around asset sales and legal battles, the company’s fate ultimately rests on a single negotiation. DZ Bank and HVB must agree to extend a standstill agreement until autumn 2026. Without their approval, the restructuring plan finalized under the StaRUG framework in May 2025 loses its legal foundation.

A small but critical cash injection is due on April 30, when BayWa expects to receive a residual payment of around €107 million from the already-completed sale of its Dutch subsidiary Cefetra Group. That sum comprises €45 million in deferred purchase price and roughly €62 million from the repayment of shareholder loans. If the money arrives on time, it will strengthen the company’s hand in talks with its core lenders.

But it does not solve the structural problem. BayWa does not expect to have a certified 2025 annual report until the fourth quarter of 2026. Until then, there is no reliable basis for any fundamental valuation—and the decisive turning points remain months away. The shares rose 10% on the day to €14.45, but remain more than 25% below their 52-week high from July 2025.